The novel approach of the medication represents a significant breakthrough in the management of type 2 diabetes. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide363249.designi1.com/62792802/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment